Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Dow
Queensland Health
Covington
Healthtrust
Deloitte
Julphar
Fish and Richardson

Generated: September 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088388

« Back to Dashboard

NDA 088388 describes SCANDONEST L, which is a drug marketed by Deproco and is included in one NDA. It is available from six suppliers. Additional details are available on the SCANDONEST L profile page.

The generic ingredient in SCANDONEST L is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 088388
Tradename:SCANDONEST L
Applicant:Deproco
Ingredient:levonordefrin; mepivacaine hydrochloride
Patents:0
Pharmacology for NDA: 088388
Ingredient-typeAmides
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 088388
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SCANDONEST L levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 088388 ANDA Septodont, Inc. 0362-1097 0362-1097-80 5 BLISTER PACK in 1 CARTON (0362-1097-80) > 10 CARTRIDGE in 1 BLISTER PACK > 1.7 mL in 1 CARTRIDGE
SCANDONEST L levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 088388 ANDA Henry Schein Inc. 0404-6740 0404-6740-05 5 BLISTER PACK in 1 CARTON (0404-6740-05) > 10 CARTRIDGE in 1 BLISTER PACK > 1.7 mL in 1 CARTRIDGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.05MG/ML;2%
Approval Date:Oct 10, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Baxter
Chinese Patent Office
Express Scripts
Mallinckrodt
Cerilliant
US Department of Justice
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.